– in 2023: U.S. reported 9,633 cases – a rise of 15.6% from the prior year.
– Approximately 13 million Americans harbor “inactive” TB; about one in ten can transition to active/symptomatic states capable of spreading infection.
– This could lead to strains resistant to standard medication (“superbugs”) that are expensive to treat.
Read More: Discover Magazine article
The resurgence of tuberculosis represents a meaningful global health challenge with relevance for India, which has historically been one of the countries with high TB burdens.Rising trends in multidrug-resistant tuberculosis pose serious implications for public healthcare systems worldwide by increasing treatment costs and complicating medical responses – outcomes acutely relevant for developing nations where healthcare resources are already stretched thin.
India has been actively involved in combating TB through programs like National tuberculosis Elimination Program focused on early detection via technology and expanded access to anti-TB medication such as bedaquiline against drug-resistant strains highlighted in global discourse.
The increasing prevalence across demographics (e.g., children under age groups per EU data), combined with steady transmission rates post-pandemic suggests India must remain vigilant proactively scaling community-centric awareness regarding hygiene practices testing rural block-chain partnerships